Form 4: MeiraGTx CEO Alexandria Forbes Sells 62,000 Shares

MeiraGTx Holdings plc President and CEO Alexandria Forbes sold 62,000 ordinary shares via a pre-arranged 10b5-1 trading plan.

Summary

• Alexandria Forbes, President and CEO of MeiraGTx Holdings plc, sold 62,000 ordinary shares on May 19, 2026.
• The shares were sold at a weighted average price of $9.17 per share.
• The transaction was executed under a Rule 10b5-1 trading plan adopted on November 18, 2025.
• Following the transaction, the reporting person retains beneficial ownership of 1,387,695 ordinary shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed under a pre-planned 10b5-1 arrangement, which is standard practice for executive financial planning.

Positives

• The sale was conducted through a pre-established Rule 10b5-1 trading plan, which is a standard mechanism for executives to sell shares without triggering insider trading concerns.

Negatives

• The transaction represents a reduction in the CEO's direct equity stake in the company.

Risks

• Insider selling can sometimes be perceived negatively by the market, potentially signaling that the executive believes the stock price has reached a near-term peak.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that executive share sales via 10b5-1 plans are common in the biotechnology sector and are generally viewed as routine liquidity events rather than indicators of company performance.

Comparison to Industry Standards

• The use of a 10b5-1 plan is consistent with standard corporate governance practices for C-suite executives in publicly traded biotech firms.

Stakeholder Impact

• Minimal impact expected as the sale was pre-planned and represents a small portion of the CEO's total holdings.

Key Dates

Keywords

MeiraGTx, MGTX, Insider Trading, Form 4, Alexandria Forbes, Biotech